RxDoctor Payments Data

Scott Duemler, MD

Family Medicine · Byron Center, MINPI 1306898036

Payments from drug & device makers

$1,256in general payments, 2019–2025

Across 68 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$222
  • AstraZeneca$210
  • Amgen$173
  • GSK$167
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$116
  • Lilly USA, LLC$95
  • plus $272 from 10 others

What the payments were for

  • Food & beverage$1,256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,256 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$26,865
Medicare patients
70
Services billed
486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban50$66,545
XareltoRivaroxaban31$30,156
RybelsusSemaglutide16$25,336
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$17,833
JardianceEmpagliflozin19$17,406
OzempicSemaglutide11$14,541
Combivent RespimatIpratropium/Albuterol Sulfate28$14,476
Atorvastatin Calcium501$8,705
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen322$6,761
FarxigaDapagliflozin Propanediol11$6,065
Metoprolol Succinate219$5,955
Albuterol Sulfate HfaAlbuterol Sulfate111$4,232
Gabapentin180$4,173
Duloxetine Hcl105$3,640
Omeprazole187$3,585

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$222$66,54550 claims
GSKTrelegy Ellipta$167$17,83323 claims
AstraZenecaFarxiga$210$6,06511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Byron Center

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →